Route of administration: Subcutaneous or intravenous
Prophylactic: 5,000 units tid
Therapeutic: Bolus 5-10,000 units followed by 1-2,000 units/hour to achieve heparin levels of 0.35-0.7 anti-Xa units Low Molecular Weight Heparin Daltaparin
Prophylactic: 2500 units qday (low risk); 5000 units q day (high-risk abdominal surgery)
Therapy: 100 units/kg every 12 hours Enoxaparin
Prophylactic: 40 mg/day or 30 mg every 12 hours (orthopedic indications)
Therapy: 1 mg/kg every 12 hours or 1.5 mg/kg in low risk patients Nadroparin
Prophylactic: 2850 units every 24 hours (38 units/kg in high risk patients)
Therapy: 86 units/kg every 12 hours or 171 units/kg every 24 hours Tinzaparin
Prophylactic: 3500 units every 24 hours (4500 units in high risk patients)
Therapy: 175 units every 24 hours Pentasaccharide Fondaparinux
Prophylaxis: 2.5 mg every 24 hours
Therapy: 7.5 mg every 24 hours (consider 5.0 mg in patients under 50kg and 10 mg in patients over 100 kg)
For acute venous thrombosis the approved doses are either enoxaparin 1 mg/kg every 12 hours or tinzaparin 175 ^/kg every day (see Table 22.2 for all LMWH doses). For low-risk patients (calf vein thrombosis, upper extremity thrombosis), once-a-day therapy with 1.5 mg/kg of enoxaparin can be used, but this may not be adequate for higher-risk patients and twice a day therapy should be used. One trial did demonstrate that once daily dalteparin was inferior to twice a day therapy for venous disease and this dosing should not be used. For short courses of therapy, most patients do not need to have LMW heparin levels drawn. Patients who are very obese (>two times ideal body weight), who have severe liver or heart failure, who are pregnant, or on long-term LMWH therapy should have levels performed.
LMWH are renally cleared and the dose needs to be adjusted for renal function. For patients with creatinine clearance between 10-30 cc/hr the dose of enoxaparin is 0.65 mg/kg q12 hours. In patients on dialysis or with creatinine clearances less that 30 cc, the dose of enoxaparin should be 1 mg/kg/day. The pharmacokinetics of LMWH are not affected by weight and there should be no capping or adjusting of doses for overweight patients. Levels are drawn four hours after injection and the therapeutic range for enoxaparin is 0.7-1.2 anti-Xa units. Therapeutic ranges for other low molecular heparins have not been as well established.
The LMW heparins can be used in either inpatient or outpatient settings. Although LMW heparin is more expensive, inpatient savings can be realized since multiple aPTT's, daily platelet counts, and continuous intravenous therapy are not needed. In addition, it was in the general inpatient population that clinical trials demonstrated LMW heparin's effectiveness and safety over that of standard heparin.
Was this article helpful?
Awesome Ways To Get Over Your Mentality That Keeps you Overweight! This Book Is One Of The Most Valuable Resources In The World When It Comes To Results In Your Slim-down and Health Efforts! Day in day out we keep ourselves absorbed with those matters that matter the most to us. A lot of times, it might be just to survive and bring in some money. In doing so we at times disregard or forget about the extra matters that are essential to balance our lives. They’re even more essential to supply real meaning to our world. You have to pay attention to your wellness.